Jury Upholds Genentech Patents: In an important...
- Share via
Jury Upholds Genentech Patents: In an important decision for biotechnology giant Genentech Inc., the company said a federal district court jury in Delaware upheld the validity of three patents for its heart drug, TPA. Genentech had sued Wellcome PLC subsidiaries and Genetics Institute Inc. in June, 1988, for patent infringement of the clot-dissolving drug it markets under the name Activase and for the process used to make it. Genentech lost a similar case in London in November, 1988, when Britain’s Appeals Court ruled Genentech’s TPA patent did not cover Wellcome’s version of the drug.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
